The Pharmacy Times® Hepatitis resource center provides clinical news and articles, pertaining to the Food and Drug Administration approved therapies to treat Hepatitis A, B, and C. Additionally, pharmacists will find coverage from pertinent conferences and meetings, videos, podcasts, and other associated content.
The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.
Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.
An overlap between substance use disorder and HCV presents an important area for screening high-risk populations.
The Pharmacy Times® Hepatitis condition center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel diabetes therapies, and the newest data from all phases of clinical trials and studies in the space.
Among its other resources are a wealth of videos including interviews with thought leaders and experts in the inflammatory liver disease, and moderated Peer Exchange panels featuring the world’s leading hepatologists and gastroenterologists discussing best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of treating the disease, and much more.